Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / Training / Seminars and Symposia / Treatment Outcomes in Relapsed/Refractory Hodgkin Lymphoma: Targeted Therapy and Autologous Stem Cell Transplant

Treatment Outcomes in Relapsed/Refractory Hodgkin Lymphoma: Targeted Therapy and Autologous Stem Cell Transplant

Meghan Karuturi, MD, University of Texas, MD Anderson Cancer Center
When Nov 22, 2013
from 08:00 AM to 09:00 AM
Where 3101 POB
Add event to calendar iCal

Hematology/Oncology Seminar